Literature DB >> 19721970

Pharmaceutical services evaluation in Brazil: broadening the results of a WHO methodology.

Isabel Cristina Martins Emmerick1, Vera Lucia Luiza, Vera Lucia Edais Pepe.   

Abstract

The objective of this paper is to explore and analyze the results of the Diagnosis of the Pharmaceutical Situation in Brazil (DiagAF-Br) from a regional perspective. The study made use of an exploratory approach of multiple cases based on the DiagAF-Br data collected in five Brazilian states. A descriptive analysis of selected indicators was performed in each of the Brazilian states in three pharmaceutical dimensions: access, quality, and rational use of medicines. The mainly results concerning the percentage of completed prescriptions varied from 1.1% in the State of Goiás to 98.6% in Espírito Santo; the percentage of patients who know how to take their medicines varied from 60.4% in Sergipe to 93.3% in Rio Grande do Sul. Educational level showed to be an important predictor of knowledge on how to use medicines, especially relevant when prescription is completed. The average number of prescribed medicines, approximately 2.1, did not show any difference between the visited sites. Different levels of management capacity and services organization were identified, suggesting the need for more adequate strategies to improve access, quality and mainly rational use of medicines in Brazil.

Entities:  

Mesh:

Year:  2009        PMID: 19721970     DOI: 10.1590/s1413-81232009000400036

Source DB:  PubMed          Journal:  Cien Saude Colet        ISSN: 1413-8123


  2 in total

1.  Prescribing indicators in primary health care in Belo Horizonte, Brazil: associated factors.

Authors:  Marina Guimarães Lima; Kátia Reis Dutra; Ursula Carolina Morais Martins
Journal:  Int J Clin Pharm       Date:  2017-06-19

2.  Indicators related to the rational use of medicines and its associated factors.

Authors:  Marina Guimarães Lima; Juliana Álvares; Augusto Afonso Guerra; Ediná Alves Costa; Ione Aquemi Guibu; Orlando Mario Soeiro; Silvana Nair Leite; Margô Gomes de Oliveira Karnikowski; Karen Sarmento Costa; Francisco de Assis Acurcio
Journal:  Rev Saude Publica       Date:  2017-11-13       Impact factor: 2.106

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.